Edit: I found the PR and confirmed "TAS-102 and bevacizumab will be administered for three of four weeks in a four-week cycle, and leronlimab (at doses of 350 mg or 700 mg) will be administered weekly."
https://www.cytodyn.com/newsroom/detail/623/c...n-phase-ii